Brexit
Click here to find out more
Brexit – what's the deal for business?
12 January 2021
Briefing
by multiple authors
Life sciences & healthcare
Click here to find out more
Will the UK government's COVID-19 dosing regime gamble pay off?
11 January 2021
Briefing
by Alison Dennis and Justyna Ostrowska
Life sciences & healthcare
Click here to find out more
One Nucleus Genesis Digital 2020 – Key takeaways from our cell and gene therapy panel session
6 January 2021
Quick read
Life sciences & healthcare
Click here to find out more
What the UK-EU Trade and Cooperation Agreement means for pharma and medical device companies
31 December 2020
Briefing
Brands & advertising
Click here to find out more
Novartis vs Bayer
A reminder to always substantiate claims in pharma ads
28 December 2020
Quick read
by Judith Krens and Marthe Riewald
Digital health
Click here to find out more
A new era for digital health in Germany
10 December 2020
Briefing
Coronavirus
Click here to find out more
Next Normal Legal ‒ The Legal Situation in Germany after Covid-19
8 December 2020
Technology, media & communications
Click here to find out more
Life sciences and healthcare predictions 2021: more politics
4 December 2020
Briefing
by Alison Dennis and Justyna Ostrowska
Life sciences & healthcare
Click here to find out more
8+2+1 plus what? How UK data and market exclusivity rights will be affected from 1 January 2021
3 December 2020
Briefing
by Alison Dennis and Paul England, DPhil
Data protection & cyber
Click here to find out more
Global Data Hub - Health data
27 November 2020
Quick read
by multiple authors
Life sciences & healthcare
Click here to find out more
Biologics and biosimilars litigation update
25 November 2020
Quick read
by multiple authors
Life sciences & healthcare
Click here to find out more
Russian coronavirus vaccine – approval process in Hungary and the EU
Available in Hungarian
24 November 2020
Briefing